Xtant Medical Holdings (XTNT) Free Cash Flow Growth (1y) (2011 - 2025)
Xtant Medical Holdings (XTNT) Free Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn | 133.09% |
| 10 | Xtant Medical Holdings | 60.50 Mn | 43.17 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 209.42% |
| Jun 30, 2025 | 116.10% |
| Mar 31, 2025 | 101.33% |
| Dec 31, 2024 | 99.45% |
| Sep 30, 2024 | 5.79% |
| Jun 30, 2024 | -92.57% |
| Mar 31, 2024 | -141.69% |
| Dec 31, 2023 | 53.20% |
| Sep 30, 2023 | -57.55% |
| Jun 30, 2023 | -843.73% |
| Mar 31, 2023 | -81.52% |
| Dec 31, 2022 | -1,245.32% |
| Sep 30, 2022 | -92.74% |
| Jun 30, 2022 | -118.17% |
| Mar 31, 2022 | 19.52% |
| Dec 31, 2021 | -173.02% |
| Sep 30, 2021 | -338.03% |
| Jun 30, 2021 | 947.52% |
| Mar 31, 2021 | 9.67% |
| Dec 31, 2020 | 150.82% |